88IV - PR Newswire Asia's news


MGI Tech Celebrates 10 Years of Innovation, Empowering 3,560 Users Across Six Continents SHENZHEN, China , April 13, 2026 /PRNewswire/ -- MGI Tech Co., Ltd. (MGI), a company dedicated to developing core tools and technologies that drive innovation in life sciences, celebrates its 10th anniversary, ... 2026-04-13T Biotechnology Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals
Haisco Enters into Exclusive License Agreement with AbbVie to Develop Novel Medicines for Pain BEIJING , April 13, 2026 /PRNewswire/ -- On April 10, 2026, Haisco Pharmaceutical Group Co., Ltd. (Ticker Code: 002653) announced that it has entered into an exclusive licensing agreement with AbbVie ... 2026-04-13T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
AnBogen Therapeutics to Present Dual Breakthroughs for Imofinostat (ABT-301) at AACR 2026: Addressing Immunotherapy Barriers in CRC and Chemo-resistance in Pancreatic Cancer TAIPEI , April 13, 2026 /PRNewswire/ -- AnBogen Therapeutics, a clinical-stage biotechnology company focused on precision oncology, today announced that two key research abstracts regarding its lead ... 2026-04-13T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Telix and Regeneron Announce Strategic Radiopharma Collaboration Telix and Regeneron to co-develop and co-commercialize next-generation radiopharmaceutical therapies in a 50/50 cost and profit-sharing model. Collaboration combines Telix's expertise in radiopharmaceutical ... 2026-04-13T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Miracell Receives FDA 510(k) Clearance for SMART M-CELL PRP Concentration System and SMART M-CELL Bone Marrow Concentration System Blood- and bone marrow-based efficient growth factors extraction system demonstrates substantial equivalence and high cell viability ... 2026-04-10T Biotechnology Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Vivatides Therapeutics Announces Oversubscribed $54 Million Series A Financing to Accelerate Extrahepatic RNA Therapeutics Development Advancing next-generation RNA therapeutics beyond the liver through breakthrough delivery technologies SUZHOU, China and BOSTON , April 10, 2026 /PRNewswire/ -- Vivatides Therapeutics, a global ... 2026-04-10T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
NovogeneAIT Genomics Appointed as Service Provider to Advance Large-Scale Proteomics for PRECISE-SG100K Cohort in Singapore SINGAPORE , April 10, 2026 /PRNewswire/ -- NovogeneAIT Genomics announces its appointment as the designated service provider for the PRECISE -SG100K proteomics project. In this role, NovogeneAIT ... 2026-04-10T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
ArkBio Completed Dosing of First Cohort in Australian Phase I Trial of Antiviral Drug-Fc Conjugate Drug AK0406 SHANGHAI , April 10, 2026 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced that the first cohort of healthy volunteers has been dosed in a phase I clinical ... 2026-04-10T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Ailux Appoints Maria Belvisi, Ph.D., as Chief Scientific Officer Professor Belvisi joins from AstraZeneca, where she served as Senior Vice President, Research & Development, Respiratory & Immunology and built one of the most productive early R&D organizations ... 2026-04-10T Biotechnology Computer/Electronics Health Care/Hospital Medical/Pharmaceuticals
Oricell Therapeutics Closes $110 Million Pre-IPO Financing to Accelerate Global Development of Solid Tumor CAR-T Therapies SHANGHAI , April 10, 2026 /PRNewswire/ -- Oricell Therapeutics Holdings Limited ("Oricell"), a global clinical-stage biotechnology company pioneering innovative cancer immunotherapies, today ... 2026-04-10T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

PR Newswire Asia's news > Biotechnology